AIVI1.780%
as of Jul 17
MED
UnknownMediolanum SpA
Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address weight loss in the United States. The company offers weight loss, weight management, and healthy living products comprising bars, cereals, snack straws, hot chocolate, hearty choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, soft bakes, soups, essential amino acid blends, whey protein, hot beverages, brownies, and mini meals under the Essential Fuelings, OPTAVIA ASCEND, and OPTAVIA ACTIVE categories, as well as daily nutrient packs, including multivitamins, minerals, and omega-3 fatty acid supplements.
Close · 3M
-2.72%
Held by 1 AI ETF
Signal performance
Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.
Buy signals23
Win rate9% (2/23)
Avg buy return-7.70%
AIVI · Weight decrease · 3d
Mediolanum SpA, currently priced at $10.26, has experienced significant declines, with a 30-day return of -16.4% and a one-year return of -29.9%. WisdomTree's AIVI ETF, which employs AI selection within a developed-international value-factor pool, responded to this price context by consecutively reducing MED’s weight from 1.8006% to 1.7811% between July 14 and July 16, 2026. Despite trading at 67% of its 52-week high, this pattern suggests the AI model perceived a further erosion of Mediolanum's fundamental value characteristics, even as it screens for international value stocks. This rebalancing indicates that the AI's periodic assessment identified better opportunities or higher risks elsewhere among the roughly 100 stocks in AIVI's international developed-market value portfolio.
weight 1.802% → 1.781% (-0.021 pp)·stock down 12.1% in the 30 days before
Jul 16·entry $10.50·now $10.38
-1.14%
since Jul 16
AIVI · Weight decrease · 2d
Mediolanum SpA, trading at $10.50 and 69% of its 52-week high following a -28.0% one-year return, initially appeared to fit AIVI’s strategy of identifying international developed-market value stocks through its AI selection method. The AI-driven ETF increased its allocation to MED significantly from 1.3540% to 1.8143% in early July, before exhibiting a pattern of consecutive weight decreases on July 14th and 15th, moving from 1.8018% to 1.7824%. This divestment occurred as MED experienced a -14.2% return over 30 days, suggesting AIVI's AI overlay detected a shift in Mediolanum's fundamental value characteristics, indicating it might no longer meet the model's criteria for a compelling international value opportunity despite its lower price point. The AI's continuous reassessment led to a reduction in exposure, prioritizing its value framework over simply holding a stock that has declined in price.
weight 1.802% → 1.782% (-0.019 pp)·stock down 10.6% in the 30 days before
Jul 15·entry $10.63·now $10.38
-2.35%
since Jul 15
AIVI · Accumulation · 5d
The observed weight changes in MED for AIVI reveal a pattern of gradual accumulation culminating in a material step-up on July 6. This behavior aligns with AIVI's AI-driven method, which targets developed-international value stocks, identifying companies like Mediolanum SpA that have experienced significant price declines. With MED trading at $10.61, a substantial 27.7% below its price a year ago and at 70% of its 52-week high, the stock presents as a value opportunity within its 52-week range of $9.53 to $15.22. The relatively smaller daily increases from June 30 to July 2, followed by the larger move on July 6, suggest the AI's continuous evaluation alongside a periodic rebalancing action, allowing AIVI to capitalize on such undervalued international assets within its approximately 100-stock portfolio.
weight 1.334% → 1.802% (+0.468 pp)·stock down 9.1% in the 30 days before
Jul 13·entry $11.03·now $10.38Fresh
-5.89%
since Jul 13
AIVI · Accumulation · 5d
The initial gradual accumulation in MED’s weight within AIVI, moving from 1.3183% to 1.3540% before a significant jump to 1.8143%, signals a deliberate response to changing market conditions. This methodical increase in allocation, particularly after the company experienced a 12.0% decrease in its 30-day return and a 21.5% decline over the last year, aligns directly with AIVI’s strategy of identifying international developed-market value stocks through its AI overlay. With Mediolanum SpA trading at $11.03, residing at 72% of its 52-week high after such declines, the AI selection model likely recognized a compelling value proposition. AIVI's periodic rebalancing method explains the stepped nature of the weight adjustment, allowing the AI to integrate this new perspective on MED's relative value into its portfolio.
weight 1.318% → 1.787% (+0.469 pp)·stock down 12.0% in the 30 days before
Jul 10·entry $10.72·now $10.38Fresh
-3.17%
since Jul 10
AIVI · Weight decrease · 2d
The WisdomTree AIVI ETF’s consecutive weight decrease in Mediolanum SpA suggests the AI selection algorithm is recalibrating its allocation based on the company's perceived value characteristics. Operating within a developed-international value-factor pool, the AI continually assesses its ~100 international developed-market value stocks for optimal fit. This current reduction in MED’s weighting suggests the AI has identified a weakening in its relative value proposition, even as the stock has seen a -16.0% return over the last 30 days. The fund’s periodic rebalancing mechanism allows the AI to gradually adjust positions as new data informs its assessment of the most compelling value opportunities.
weight 1.814% → 1.782% (-0.032 pp)·stock down 11.8% in the 30 days before
Jul 8·entry $10.67·now $10.38
-2.72%
since Jul 8
AIVI · Accumulation · 5d
Mediolanum SpA's current price of $10.67, reflecting a -18.5% 30-day return and placing it at 70% of its 52-week high, directly influences WisdomTree's AIVI, which targets developed-international value stocks. This price performance, particularly the recent downturn following a largely negative one-year return, would activate the value-factor criteria central to AIVI's AI selection method within the international value segment. The AI overlay then initiated a gradual accumulation, increasing MED's weight from 1.3140% on June 24, 2026, to a substantial 1.8143% by July 6, 2026. This move suggests AIVI's algorithm identified Mediolanum as a compelling value opportunity at its current price level.
weight 1.314% → 1.790% (+0.476 pp)·stock down 11.2% in the 30 days before
Jul 7·entry $10.89·now $10.38Fresh
-4.68%
since Jul 7
AIVI · Accumulation · 6d
WisdomTree's AIVI ETF, which employs AI selection for its portfolio of around 100 international developed-market value stocks, has systematically increased its allocation to Mediolanum SpA (MED). This gradual accumulation, moving from 1.3124% to 1.8143% in eight trading days, indicates the AI's ongoing assessment identified MED as a suitable candidate within its value-factor pool. The company’s current valuation, including a -13.5% 30-day return, directly supports the fund's strategy to capture international value. Despite the fund rebalancing periodically rather than daily, the AI's continuous evaluation prompted a stronger weighting in MED at the $10.89 price point, reflecting the specific criteria of its AI overlay.
weight 1.312% → 1.814% (+0.502 pp)·stock down 9.8% in the 30 days before
Jul 6·entry $11.04·now $10.38Fresh
-5.98%
since Jul 6
AIVI · Accumulation · 5d
Currently at $10.96, MED trades at 72% of its 52-week high, having registered a -13.0% return over the past 30 days, contrasting with a +4.6% 90-day gain and a -22.4% annual decline. This price trajectory, showing a recent dip within its annual range and above its $9.53 52-week low, likely signaled an entry opportunity for AIVI's AI selection method. The ETF, which targets developed-international value stocks, operates in an underserved market niche and is designed to identify companies at appealing price levels. The observed gradual accumulation, with MED's weight in AIVI increasing from 1.3201% to 1.3540% over eight trading days, indicates the AI system systematically added to its position. This steady buying suggests the algorithm identified MED as aligning with its international value criteria, specifically capitalizing on the recent price drop as a potentially attractive entry point for a stock within its developed-international universe.
weight 1.320% → 1.354% (+0.034 pp)·stock down 11.3% in the 30 days before
Jul 2·entry $10.96·now $10.38Fresh
-5.29%
since Jul 2
AIVI · Accumulation · 5d
MED, trading at $11.03, sits at 72% of its 52-week high of $15.22, having recently posted a 30-day return of -12.4% against a 90-day return of +4.1% and a 1-year return of -22.2%. This price action, positioning the stock significantly below its yearly peak after a recent downturn, likely presented Mediolanum SpA as a developed-international value opportunity for WisdomTree's AIVI fund. The AI overlay within AIVI’s strategy, focused on international value, appears to have identified the stock as a fitting addition at this current valuation. The observed gradual accumulation, with AIVI’s weight in MED increasing from 1.3096% to 1.3451% over several trading days, reflects a systematic, incremental build-up consistent with the ETF's periodic rebalancing approach rather than a single, rapid acquisition.
weight 1.310% → 1.345% (+0.035 pp)·stock down 13.1% in the 30 days before
Jul 1·entry $11.03·now $10.38Fresh
-5.89%
since Jul 1
AIVI · Accumulation · 5d
Mediolanum SpA currently trades at $10.61, positioning it at 70% of its 52-week high after recording a -14.8% return over the past 30 days and a -21.3% decline over the last year. This suppressed price environment directly aligns with AIVI's strategy, which employs an AI overlay to select developed-international value stocks. The fund's AI system likely identified MED as an attractive value opportunity given its recent price depreciation. Consequently, a gradual accumulation pattern emerged, with the stock's weight in the portfolio rising methodically from 1.2931% to 1.3336% between June 16th and June 30th. This incremental buying suggests the AI is progressively adding to its position, capitalizing on the stock's lower price levels within its specific international value mandate.
weight 1.293% → 1.334% (+0.041 pp)·stock down 15.3% in the 30 days before
Jun 30·entry $10.61·now $10.38Fresh
-2.17%
since Jun 30
AIVI · Accumulation · 5d
WisdomTree's AIVI, which utilizes an AI overlay to select from a developed-international value-factor pool, appears to be identifying Mediolanum SpA (MED) as an emerging value opportunity. The fund, typically holding around 100 international developed-market value stocks, initiated a gradual accumulation of MED shares, reflecting the AI's assessment of its intrinsic value. This accumulation, evidenced by the weight increasing from 1.2706% to 1.3482% across several trading days in June, suggests the AI system is responding to recent market dynamics for the stock. With MED currently trading at $10.70, which is 70% of its 52-week high, the AI is likely detecting a buying opportunity created by the recent -14.3% 30-day return, aligning with AIVI's international value mandate even with its periodic rebalancing schedule. This targeted buying in a European financial company underscores AIVI's specific strategy within the comparatively underserved international value ETF market.
weight 1.271% → 1.318% (+0.048 pp)·stock down 17.4% in the 30 days before
Jun 26·entry $10.51·now $10.38Fresh
-1.24%
since Jun 26
AIVI · Accumulation · 6d
Mediolanum SpA (MED), currently priced at $10.51, has experienced a 16.5% decline over the past 30 days and trades at 69% of its 52-week high. These metrics suggest the company has entered a valuation range that aligns with the international value component of WisdomTree AIVI's selection criteria. The AI overlay in AIVI’s methodology appears to have identified Mediolanum’s recent price weakness as an opportune entry point, initiating a gradual accumulation that aligns with the stock's short-term underperformance. AIVI’s weight in MED increased from 1.2462% on June 12 to 1.3482% by June 25, demonstrating the fund's AI-driven method systematically adding shares within its developed-international value pool as the stock's valuation became more attractive.
weight 1.246% → 1.348% (+0.102 pp)·stock down 22.1% in the 30 days before
Jun 25·entry $10.20·now $10.38Fresh
+1.76%
since Jun 25
AIVI · Accumulation · 6d
AIVI’s AI selection method within its developed-international value universe likely drove the methodical accumulation of Mediolanum SpA. This strategy targets international value opportunities, and MED’s -17.6% 30-day return, alongside its current position at 68% of its 52-week high, presented a compelling valuation entry point. The gradual increase in weight from 1.2284% to 1.3140% over several trading days suggests a periodic rebalance, aligning with the fund’s systematic approach to managing its approximately 100 international value stocks. This indicates the AI identified MED as a suitable candidate for increased allocation based on its defined value criteria following recent price depreciation.
weight 1.228% → 1.314% (+0.086 pp)·stock down 17.7% in the 30 days before
Jun 24·entry $10.36·now $10.38Fresh
+0.19%
since Jun 24
AIVI · Accumulation · 6d
The AI-managed AIVI fund has demonstrated a consistent, incremental accumulation of Mediolanum SpA (MED) over two weeks, increasing its weight from 1.2232% to 1.3124% with daily adjustments rather than large, episodic changes. This measured growth in position aligns with the fund's international value-factor approach, particularly given MED's current price of $10.62, which sits at 70% of its 52-week high after experiencing a -14.4% decline over the last 30 days and a -21.9% drop over the past year. The AI selection methodology within AIVI's developed-international value pool appears to be leveraging this period of lower share prices for MED, incrementally adding to the holding as the stock trades significantly below its 52-week high. This gradual, almost daily, build-up suggests a continuous re-evaluation by the AI, seizing the present valuation to deepen exposure to an international value asset that has seen considerable short-term and long-term price decreases.
weight 1.223% → 1.312% (+0.089 pp)·stock down 15.9% in the 30 days before
Jun 23·entry $10.62·now $10.38Fresh
-2.26%
since Jun 23
AIVI · Accumulation · 7d
The observed trend for Mediolanum SpA in AIVI shows a steady increase in allocation over the past two weeks, moving from 1.2093% to 1.3201%. This incremental accumulation coincides with Mediolanum’s recent 30-day return of -12.5% and a 1-year return of -16.9%, placing it at 72% of its 52-week high. The recent price depreciation, particularly the -12.5% 30-day return, likely signaled an attractive value proposition for AIVI's AI, which selects within its developed-international value-factor pool. This steady, incremental increase in allocation, spanning multiple trading days, is consistent with AIVI's strategy of periodic rebalancing, allowing the AI to systematically build its position in Mediolanum SpA based on its value assessment.
weight 1.209% → 1.320% (+0.111 pp)·stock down 12.5% in the 30 days before
Jun 22·entry $11.02·now $10.38Fresh
-5.81%
since Jun 22
AIVI · Accumulation · 6d
Over ten trading days, the AIVI ETF systematically increased its weighting in Mediolanum SpA, with its position moving from 1.2153% to 1.3096%. This gradual accumulation within AIVI’s international value + AI overlay framework appears to capitalize on MED’s recent market performance. Currently priced at $11.04, Mediolanum has experienced a 13.0% decline over 30 days and a 13.1% decline over one year, placing it at 73% of its 52-week high. Such a consistent price depreciation likely triggers the AI’s value-factor screening criteria, prompting AIVI to methodically add to its exposure as Mediolanum SpA presents an increasingly attractive valuation opportunity in the developed-international market.
weight 1.215% → 1.310% (+0.094 pp)·stock down 12.3% in the 30 days before
Jun 18·entry $11.04·now $10.38Fresh
-5.98%
since Jun 18
AIVI · Accumulation · 6d
Mediolanum SpA's current price of $11.25, trading at 74% of its 52-week high of $15.22, indicates a potential value entry point for AIVI's international value-factor pool. Its recent 30-day return of -11.3% and 1-year return of -9.8% suggest a downward price trend, aligning with the criteria for a developed-international value stock. WisdomTree's AI selection method within AIVI initiated a gradual accumulation of MED, evidenced by the weight increasing from 1.2072% on June 4th to 1.2931% by June 16th. This consistent buying reflects the AI recognizing Mediolanum SpA as a suitable candidate within its underserved international value market segment following these price movements. The pattern of increased exposure over several trading days suggests the AI system continuously confirmed the stock's value proposition during this period of suppressed pricing.
weight 1.207% → 1.293% (+0.086 pp)·stock down 9.7% in the 30 days before
Jun 16·entry $11.27·now $10.38Fresh
-7.90%
since Jun 16
AIVI · Accumulation · 6d
WisdomTree's AIVI fund, utilizing AI selection within its developed-international value-factor pool, has shown a methodical accumulation of Mediolanum SpA. The fund’s AI algorithm likely identified value in MED, evidenced by the stock’s current price of $11.94 and its trading at 78% of its 52-week high after experiencing a 12.3% one-year decline. This gradual increase in position, observed from 1.2003% to 1.2706% over several days, suggests the AI is building a stake based on its periodic rebalance schedule. Such a calculated move aligns with AIVI's style, managing approximately 100 international developed-market value stocks, where the AI seeks opportunities in comparatively underserved market segments.
weight 1.200% → 1.271% (+0.070 pp)·stock down 5.2% in the 30 days before
Jun 15·entry $11.94·now $10.38Fresh
-13.07%
since Jun 15
AIVI · Accumulation · 5d
The AIVI ETF progressively increased its allocation to Mediolanum SpA (MED), moving from 1.2238% to 1.2462% over eight trading days in early June 2026. This subtle, consistent accumulation makes sense for a fund employing AI selection within a developed-international value-factor pool, which rebalances periodically rather than daily. Given MED's 1-year return of -10.7%, placing it significantly below its 52-week high, the stock presents a clear value characteristic the AI would target. Simultaneously, its recent 30-day return of +9.0%, despite the stock trading at 78% of its 52-week high, indicates a positive momentum shift that the AI overlay likely registered as a favorable entry point for this value play, prompting the measured upward adjustment.
weight 1.224% → 1.246% (+0.022 pp)·stock down 4.7% in the 30 days before
Jun 12·entry $11.89·now $10.38Fresh
-12.70%
since Jun 12
-12.92%
since Jun 11
-14.50%
since Jun 10
-14.21%
since Jun 5
-16.02%
since Jun 2
-16.83%
since May 13
-16.29%
since May 11
-18.20%
since May 6
-4.95%
since Apr 29
Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.